Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai Cohort Study

Cancer Letters

Volumn 334, Issue 1, 2013, Pages 34-38

  Hecht, Stephen S ^a   Murphy, Sharon E ^a   Stepanov, Irina ^a   Nelson, Heather H ^a   Yuan, Jian Min ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Biomarkers; Cotinine; NNAL; NNN; PheT; Tobacco smoke

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARCINOGEN; COTININE; PHENANTHRENE DERIVATIVE; R 1 ,T 2,3,C 4 TETRAHYDROXY 1,2,3,4 TETRAHYDROPHENANTHRENE; TOBACCO SMOKE; TOXIC GAS; TUMOR MARKER; UNCLASSIFIED DRUG; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTAN-1-OL; BIOLOGICAL MARKER; NITROSAMINE; PYRIDINE DERIVATIVE;

ADULT; CANCER RISK; CHEMICAL STRUCTURE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGUS CANCER; EXPOSURE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLITE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SHORT SURVEY; SMOKING; URINE LEVEL; ADVERSE EFFECTS; ESOPHAGUS TUMOR; LUNG TUMOR; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR; TOBACCO; URINE;

NICOTIANA TABACUM;

BIOLOGICAL MARKERS; COHORT STUDIES; COTININE; ESOPHAGEAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITROSAMINES; ODDS RATIO; PYRIDINES; RISK FACTORS; SMOKING; TOBACCO;

EID: 84891919590     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.07.016     Document Type: Review

References (37)

1. American Cancer Society. Cancer Facts & Figures 2010, American Cancer Society, Atlanta, 2010, pp. 1-72.
2. Secretan B., Straif K., Baan R., Grosse Y., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009, 10:1033-1034.
3. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83, IARC, Lyon, FR, 2004, pp. 53-1187.
4. P. Boyle, P. Levin. World Cancer Report, 2008, IARC, Lyon, FR, 2008, pp. 110-117.
5. Hecht S.S. Research opportunities related to establishing standards for tobacco products under the family smoking prevention and tobacco control act. Nicotine Tob. Res. 2012, 14:18-28.
6. Arif J.M., Dresler C., Clapper M.L., Gairola C.G., Srinivasan C., Lubet R.A., Gupta R.C. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. Chem. Res. Toxicol. 2006, 19:295-299.
7. Gupta R.C., Arif J.M., Gairola C.G. Enhancement of pre-existing DNA adducts in rodents exposed to cigarette smoke. Mutat. Res. 1999, 424:195-205.
8. Gupta R.C., Sopori M.L., Gairola C.G. Formation of cigarette smoke-induced DNA adducts in the rat lung and nasal mucosa. Cancer Res 1989, 49:1916-1920.
9. 32P-labeling test for DNA damage. Proc. Natl. Acad. Sci. USA 1981, 78:6126-6129.
10. Hecht S.S., Yuan J.-M., Hatsukami D.K. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem. Res. Toxicol. 2010, 23:1001-1008.
11. Hecht S.S., Carmella S.G., Villalta P.W., Hochalter J.B. Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem. Res. Toxicol. 2010, 23:900-908.
12. Carmella S.G., Chen M., Han S., Briggs A., Jensen J., Hatsukami D.K., Hecht S.S. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem. Res. Toxicol. 2009, 22:734-741.
13. International Agency for Research on Cancer. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide), in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 97, IARC, Lyon, FR, 2008, pp. 45-309.
14. International Agency for Research on Cancer. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vols. 1-42(Suppl. 7), IARC, Lyon, FR, 1987, pp. 120-122.
15. Zhang S., Balbo S., Wang M., Hecht S.S. Analysis of acrolein-derived 1, N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chem. Res. Toxicol. 2011, 24:119-124.
16. Yuan J.M., Koh W.P., Murphy S.E., Fan Y., Wang R., Carmella S.G., Han S., Wickham K., Gao Y.T., Yu M.C., Hecht S.S. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res. 2009, 69:2990-2995.
17. Yuan J.-M., Gao Y.-T., Murphy S.E., Carmella S.G., Wang R., Zhong Y., Moy K.A., Davis A.B., Tao L., Chen M., Han S., Nelson H.H., Yu M.C., Hecht S.S. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res. 2011, 71:6749-6757.
18. Yuan J.M., Knezevich A.D., Wang R., Gao Y.T., Hecht S.S., Stepanov I. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis 2011, 32:1366-1371.
19. Yuan J.M., Gao Y.T., Wang R., Chen M., Carmella S.G., Hecht S.S. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 2012, 33:804-809.
20. Ross R.K., Yuan J.M., Yu M.C., Wogan G.N., Qian G.S., Tu J.T., Groopman J.D., Gao Y.T., Henderson B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. The Lancet 1992, 339:943-946.
21. Yuan J.M., Ross R.K., Wang X.L., Gao Y.T., Henderson B.E., Yu M.C. Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 1996, 275:1646-1650.
22. de Waard F., Kemmeren J.M., van Ginkel L.A., Stolker A.A.M. Urinary cotinine and lung cancer risk in a female cohort. Br. J. Cancer 1995, 72:784-787.
23. Boffetta P., Clark S., Shen M., Gislefoss R., Peto R., Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1184-1188.
24. Timofeeva M.N., McKay J.D., Smith G.D., Johansson M., Byrnes G.B., Chabrier A., Relton C., Ueland P.M., Vollset S.E., Midttun O., Nygard O., Slimani N., Romieu I., Clavel-Chapelon F., Boutron-Ruault M.C., Fagherazzi G., Kaaks R., Teucher B., Boeing H., Weikert C., Bueno-de-Mesquita H.B., van Gils C., Peeters P.H., Agudo A., Barricarte A., Huerta J.M., Rodriguez L., Sanchez M.J., Larranaga N., Khaw K.T., Wareham N., Allen N.E., Travis R.C., Gallo V., Norat T., Krogh V., Masala G., Panico S., Sacerdote C., Tumino R., Trichopoulou A., Lagiou P., Trichopoulos D., Rasmuson T., Hallmans G., Riboli E., Vineis P., Brennan P. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2250-2261.
25. Church T.R., Anderson K.E., Caporaso N.E., Geisser M.S., Le C., Zhang Y., Benoit A.R., Carmella S.G., Hecht S.S. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol. Biomarkers Prev. 2009, 18:260-266.
26. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 1998, 11:559-603.
27. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999, 91:1194-1210.
28. Hecht S.S. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat. Rev. Cancer 2003, 3:733-744.
29. International Agency for Research on Cancer. tobacco smoke and involuntary smoking, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC, Lyon, FR, 2004, pp. 33-1187.
30. International Agency for Research on Cancer. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 92, IARC, Lyon, FR, 2010, pp. 35-818.
31. Wu W., Zhang L., Jain R.B., Ashley D.L., Watson C.H. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from US-brand and non-US-brand cigarettes from 14 countries. Nicotine Tob. Res. 2005, 7:443-451.
32. Kensler T.W., Ng D., Carmella S.G., Chen M., Jacobson L.P., Munoz A., Egner P.A., Chen J.G., Qian G.S., Chen T.Y., Fahey J.W., Talalay P., Groopman J.D., Yuan J.M., Hecht S.S. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 2012, 33:101-107.
33. International Agency for Research on Cancer Smokeless tobacco and some tobacco-specific N-nitrosamines, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2007, vol. 89. IARC, Lyon, FR.
34. Mirvish S.S., Sams J., Hecht S.S. Kinetics of nornicotine and anabasine nitrosation in relation to N'-nitrosonornicotine occurrence in tobacco and to tobacco-induced cancer. J. Natl. Cancer Inst. 1977, 59:1211-1213.
35. Stepanov I., Carmella S.G., Han S., Pinto A., Strasser A.A., Lerman C., Hecht S.S. Evidence for endogenous formation of N'-nitrosonornicotine in some long term nicotine patch users. Nicotine Tob. Res. 2009, 11:99-105.
36. Stepanov I., Carmella S.G., Briggs A., Hertsgaard L., Lindgren B., Hatsukami D.K., Hecht S.S. Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res. 2009, 69:8236-8240.
37. Church T.R., Anderson K.E., Le C., Zhang Y., Kampa D.M., Benoit A.R., Yoder A.R., Carmella S.G., Hecht S.S. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers 2010, 15:345-352.